WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006079611) CRYSTALLINE FORMS OF ROSUVASTATIN CALCIUM SALT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/079611    International Application No.:    PCT/EP2006/050351
Publication Date: 03.08.2006 International Filing Date: 23.01.2006
IPC:
C07D 239/42 (2006.01), A61K 31/505 (2006.01), A61P 3/06 (2006.01)
Applicants: CIBA SPECIALTY CHEMICALS HOLDING INC. [CH/CH]; Klybeckstrasse 141, CH-4057 Basel (CH) (For All Designated States Except US).
BLATTER, Fritz [CH/CH]; (CH) (For US Only).
VAN DER SCHAAF, Paul Adriaan [NL/FR]; (FR) (For US Only).
SZELAGIEWICZ, Martin [CH/CH]; (CH) (For US Only)
Inventors: BLATTER, Fritz; (CH).
VAN DER SCHAAF, Paul Adriaan; (FR).
SZELAGIEWICZ, Martin; (CH)
Common
Representative:
CIBA SPECIALTY CHEMICALS HOLDING INC.; Patent Department, Klybeckstrasse 141, CH-4057 Basel (CH)
Priority Data:
05100598.1 31.01.2005 EP
Title (EN) CRYSTALLINE FORMS OF ROSUVASTATIN CALCIUM SALT
(FR) FORMES CRISTALLINES DE SEL DE ROSUVASTATINE CALCIQUE
Abstract: front page image
(EN)Bis [ (E) -7- [4- (4-fluorophenyl ) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimid in-5-yl] - (3R, 5S) -3, 5-dihydroxyhept-6-enoic acid] ( also known as rosuvastatin ) calcium salt and hydrates can exist in new crystal forms B and C . These crystal forms provide a higher diversity on crystalline materials to optimize manufacture, formulation and biological efficiency.
(FR)La présente invention a trait à des sels et hydrates calciques de l'acide bis [ (E) -7- [4- (4-fluorophényl ) -6-isopropyl-2- [méthyl (méthylsulfonyl) amino] pyrimidin-5-yl] - (3R, 5S) -3, 5-dihydroxyhept-6-énoïque] (aussi connu comme rosuvastatine) pouvant exister dans de nouvelles formes cristallines B et C. Ces formes cristallines assurent une diversité supérieure sur des matières cristallines en vue de l'optimisation de fabrication, de formulation et d'efficacité biologique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)